Next Article in Journal
Use of After Action Reports (AARs) to Promote Organizational and Systems Learning in Emergency Preparedness
Next Article in Special Issue
Integral Dose and Radiation-Induced Secondary Malignancies: Comparison between Stereotactic Body Radiation Therapy and Three-Dimensional Conformal Radiotherapy
Previous Article in Journal
Measuring the Pattern of High Temperature Areas in Urban Greenery of Nanjing City, China
Article Menu

Export Article

Open AccessArticle
Int. J. Environ. Res. Public Health 2012, 9(8), 2936-2948;

Radioactive Iodide (131I) Excretion Profiles in Response to Potassium Iodide (KI) and Ammonium Perchlorate (NH4ClO4) Prophylaxis

Institute for Health Management and Mass Destruction Defense, College of Public Health, University of Georgia, Athens, GA 30603, USA
National Center for Environmental Health, Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA
Author to whom correspondence should be addressed.
Received: 21 June 2012 / Revised: 12 July 2012 / Accepted: 9 August 2012 / Published: 16 August 2012
(This article belongs to the Special Issue Radiation and Cancer Risk)
Full-Text   |   PDF [244 KB, uploaded 19 June 2014]   |  


Radioactive iodide (131I) protection studies have focused primarily on the thyroid gland and disturbances in the hypothalamic-pituitary-thyroid axis. The objective of the current study was to establish 131I urinary excretion profiles for saline, and the thyroid protectants, potassium iodide (KI) and ammonium perchlorate over a 75 hour time-course. Rats were administered 131I and 3 hours later dosed with either saline, 30 mg/kg of NH4ClO4 or 30 mg/kg of KI. Urinalysis of the first 36 hours of the time-course revealed that NH4ClO4 treated animals excreted significantly more 131I compared with KI and saline treatments. A second study followed the same protocol, but thyroxine (T4) was administered daily over a 3 day period. During the first 6–12 hour after 131I dosing, rats administered NH4ClO4 excreted significantly more 131I than the other treatment groups. T4 treatment resulted in increased retention of radioiodide in the thyroid gland 75 hour after 131I administration. We speculate that the T4 treatment related reduction in serum TSH caused a decrease synthesis and secretion of thyroid hormones resulting in greater residual radioiodide in the thyroid gland. Our findings suggest that ammonium perchlorate treatment accelerates the elimination rate of radioiodide within the first 24 to 36 hours and thus may be more effective at reducing harmful exposure to 131I compared to KI treatment for repeated dosing situations. Repeated dosing studies are needed to compare the effectiveness of these treatments to reduce the radioactive iodide burden of the thyroid gland. View Full-Text
Keywords: perchlorate; iodide; radioiodide; thyroid perchlorate; iodide; radioiodide; thyroid

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Harris, C.; Dallas, C.; Rollor III, E.; White, C.; Blount, B.; Valentin-Blasini, L.; Fisher, J. Radioactive Iodide (131I) Excretion Profiles in Response to Potassium Iodide (KI) and Ammonium Perchlorate (NH4ClO4) Prophylaxis. Int. J. Environ. Res. Public Health 2012, 9, 2936-2948.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top